Search results for: 'global 2026 2024'

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

The Healthcare IT Outlook 2026 examines the industry’s transition from experimentation to enterprise-scale execution, as artificial intelligence (AI), workflow orchestration, and platform consolidation reshape clinical, operational, and financial workflows. Following several years of pilot-led innovation, 2026 marks a pivotal inflection point where...

In the rapidly evolving landscape of 2026, where technological advancements are accelerating, the ability to identify, invest in, and leverage these advancements is becoming increasingly critical for organizations aiming to maintain industry leadership and ensure sustainable growth. Recognizing this imperative, Frost & Sullivan introduces (launches...

HIMSS 2026, held in Las Vegas, brought together 24,000+ stakeholders and 900+ exhibitors, underscoring the growing urgency for healthcare organizations to translate digital investments into measurable outcomes amid cost pressures, workforce shortages, and rising care complexity. Discussions at the event highlighted a clear shift from innovation-led...

The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...

This research explores the powerful global forces that will reshape business, society, and technology over the coming decade, offering a holistic view of the megatrends redefining the future operating environment. These forces span geopolitical fragmentation, demographic divergence, technological acceleration, environmental pressures, and fundament...

The "Top 10 Global Trends for 2026” report highlights the technological, geopolitical, and economic forces that will redefine the future of industries. The report covers the top trends that will transform the industries in 2026 and beyond.Some of the trends included are tariff-driven market shifts, hyper-connected reality, ethical use of AI, and ne...

In this analysis, Frost & Sullivan provides critical insights into the biotech M&A and venture capital (VC) investment, highlighting the drivers, challenges, predictions, and major trends in the biotech segment. This analysis also identifies actionable growth opportunities for industry participants to leverage. To understand the trend outlook fo...

The European Congress of Radiology (ECR) 2026 in Vienna highlighted the transformative role of artificial intelligence (AI) in imaging, advances in personalized medicine, and sustainability in healthcare. The theme “Rays of Knowledge” emphasized education, innovation, and collaboration across disciplines, with a record-high attendance and over 11,0...